Gerald D. Cagle, Director at Clearside Biomedical, Inc. (CLSD), sold 2 shares at $7.00 ($14) on 2016-06-07, disclosed to the SEC on 2016-06-07.
Open-market sale of $14 CLSD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |